First Page | Document Content | |
---|---|---|
![]() Clinical research FDA Fast Track Development Program Center for Drug Evaluation and Research Title 21 of the Code of Federal Regulations Surrogate endpoint Criticism of the Food and Drug Administration New Drug Application Medicine Food and Drug Administration Health | Add to Reading List |
![]() | United States Government Accountability Office GAO Report to the Ranking Member, Committee on Finance, U.S. SenateDocID: 1riEa - View Document |
![]() | Guideline on CT in Small Populations - AdoptedDocID: 1qPMu - View Document |
![]() | PROCEEDINGS Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and SchizophreniaDocID: 1b326 - View Document |
![]() | Do Firms Underinvest in Long-Term Research?* Evidence from Cancer Clinical Trials By Eric Budish, Benjamin N. Roin, and Heidi Williams ABSTRACT This paper investigates whether private research investments are distorted aDocID: 18ZuO - View Document |
![]() | Microsoft Word - outcomes.docDocID: 16YXk - View Document |